Karyopharm Therapeutics Inc (KPTI) stock is down -82.14% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives KPTI stock a score of 34 out of a possible 100.
That rank is chiefly influenced by a short-term technical score of 2. KPTI's rank also includes a long-term technical score of 9.
KPTI has an Overall Score of 34. Find out what this means to you and get the rest of the rankings on KPTI!
Karyopharm Therapeutics Inc (KPTI) stock has gained 2.84% while the S&P 500 is higher by 0.89% as of 1:27 PM on Monday, Oct 30. KPTI is higher by $0.02 from the previous closing price of $0.82 on volume of 859,984 shares. Over the past year the S&P 500 has gained 7.28% while KPTI is down -82.14%. KPTI lost -$1.47 per share in the over the last 12 months.
Click Here to get the full Stock Report for Karyopharm Therapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
